Inventor · name-matched record
HUANG DAWEI
2 granted patents·5 pending applications·0 citations·filing 2023–2025
25Inventor score
Files withHANGZHOU TIANLONG PHARMACEUTICAL CO LTD4BEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD2BEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
7 records- 0164US2026002160A1Sirna targeting and regulating pcsk9 gene expression and use thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0263US12545637B2Extrahepatic targeted cationic lipid compound with high efficiency and low toxicity and its compositionBEIJING YOUCARE KECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Granted Feb 10, 2026·0 cites·24 claims
- 0361US2026009035A1Galnac compound containing ribose ring or its derivative structure and oligonucleotide conjugate thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0457US2026007613A1Long-acting low-toxicity novel cationic lipid compounds and composition thereofBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0555US2026007601A1Ionizable cationic lipid compound and composition for delivering nucleic acid and use thereofBEIJING YOUCAREKECHUANG PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 0653US2026008746A1Cationic lipid compound with high efficiency, low toxicity and stable expression, and composition comprisng sameHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0751US12551500B2C6′-substituted locked nucleic acid-modified cap analog and use thereofHANGZHOU TIANLONG PHARMACEUTICAL CO LTD·Filed 2025·Granted Feb 17, 2026·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when HUANG DAWEI files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →